Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Total 13F shares
-
74,845,228
-
Share change
-
-495,199
-
Total reported value
-
$2,570,635,302
-
Put/Call ratio
-
71%
-
Price per share
-
$34.34
-
Number of holders
-
245
-
Value change
-
-$22,877,461
-
Number of buys
-
128
-
Number of sells
-
100
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2017
As of 31 Dec 2017 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 74,845,228 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BAILLIE GIFFORD & CO, Vanguard Group Inc, D. E. Shaw & Co., Inc., DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, THRIVENT FINANCIAL FOR LUTHERANS, ACADIAN ASSET MANAGEMENT LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, and NORTHERN TRUST CORP.
This table shows 245 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.